Publication of Shire plc's Annual Report 2008
...ed by regulatory
authorities and law enforcement agencies, including the US Food and Drug
Administration ('FDA'), the US Department of Justice and the
dea in the US.
Any inquiries or investigations into the operations of, or enforcement or
other regulatory action against, the Group by such regulatory aut...
Shire plc: IFRS Results for the Year Ending December 31, 2007
...ed by the FDA on
February 23, 2007 and Shire received notification from the
dea of the final
Schedule II classification for VYVANSE on May 3, 2007.
The a... of these intangible assets as they were not yet
available for use as final
dea scheduling was yet to be received.
As Shire has a pre-existing relationsh...
Sharps Compliance Corp. Announces Purchase of Medical Waste Disposal Facility and Addition of Autoclave Technology
...aste including controlled substances. The
Company is in the process of installing Drug Enforcement Agency (DEA)
approved equipment necessary to obtain
dea certification for the disposal
of controlled substances. It believes that it will be in a position to
accept unused medications and expired pharmaceut...
IFRS Information - First Half of 2007
...ed by the FDA on February
23, 2007 and Shire received notification from the
dea of the final Schedule
II classification for VYVANSE on May 3, 2007. The ac... of these intangible assets as they were not yet
available for use as final
dea scheduling was yet to be received. As Shire has a pre-existing relationshi...
Detection of Morphine and Morphine-Glucuronide in Saliva or Urine with a Rapid and Simple Method Without Derivatization on the Varian 500-MS
...oFacts Sept. 2004 (www.drugabuse.gov)
2. US Dept. Of Justice Bureau of Justice Statistics (www.ojp.usdoj.gov/bjs/dcf/du.html)
3.
dea Briefs and Background, Drugs and Drug Abuse www.usdoj.gov/dea/concern/morphine.html ...
Separation and Quantitation of R and S Enantiomers using Normal Phase Chromatography on an API 3000 LC/MS/MS System
...ity, a switching valve was incorporated to replace
dea containing mobile phase with mobile phase void of
dea over the analyte elution period, resulting in a 20...erformance requiring long retention times and high
dea levels to achieve a reproducible enantiomer separa...